Practical insights on Managing Moderate to Severe Dry Eye Disease with ciclosporin 0.09% (with case studies)
Date: 8/07/2025 (AEST)
Venue: Victoria Park, 309 Herston Rd Herston, QLD, 4006
Provider: Sun Pharma ANZ
Contact: Sarah Kim, [E] sarah.kim@sunpharma.com, [P] 0426788600
CPD Outline
Managing inflammation is critical to a dry eye treatment plan. While the role of ciclosporin in stabilising chronic inflammation of the ocular surface has often been debated, the practical considerations are frequently forgotten. This therapeutic interactive CPD event is designed to emphasise the back-and-forth discussion about the clinical applications of ciclosporin 0.09% (Cequa), focusing on real-life scenarios. Cases will be presented with a relevant case history and key findings in a format similar to what any attendee would observe in their examination.
Dry eye disease significantly affects quality of life and has a high global economic burden.
Join our interactive in-person CPD dinner educational event at Victoria Park (139 Herston Rd, Herston QLD) where Dr Beata Sander (M.Optom, MD, PhD) will explore using ciclosporin 0.09% to manage moderate-severe dry eye disease and the practical considerations to obtain the best clinical outcomes. For more information and to register your place, please click on this link https://www.eventbrite.com.au/e/practical-insights-on-managing-moderate-to-severe-dry-eye-disease-tickets-1364993776129?aff=oddtdtcreator
Learning Objectives
- Understand the vital role of inflammation in the aetiology and mechanisms of moderate-severe dry eye disease
- Evaluate the goals of therapeutic interventions for treating dry eye disease and where ciclosporin 0.09% fits in managing moderate to severe dry eye disease
- Understand the guidelines for prescribing ciclosporin 0.09% on PBS vs private script
- Discuss strategies for integrating Cequa into clinical practice, including communicating benefits and risks to patients, treatment initiation, tapering and discontinuation, and patient adherence to the treatment
Max CPD hours awarded: 2
Session Information
| Name |
|---|
| Practical Insights on Managing Moderate to Severe Dry Eye Disease with Ciclosporin 0.09% |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 2 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 2 |